Part of: S&P 100 · Pharma & Biotech · Income & Dividends

Johnson & Johnson (JNJ)

AI-powered earnings call analysis for Johnson & Johnson. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.

10 episodes 5 languages

Next Episode

Johnson & Johnson earnings call scheduled for Oct 13, 2026 (before market open)

New episode expected Oct 14, 2026

Latest Episode

Q2 2026 Earnings

6:21 • 7/15/2026

Johnson & Johnson (JNJ) - Q2 2026

0:00

6:21

Speed:

Q2 2026 Earnings

8:21 • 2026/7/15

Johnson & Johnson (JNJ) - Q2 2026

0:00

8:21

Speed:

Q2 2026 Earnings

9:07 • 15/07/2026

Johnson & Johnson (JNJ) - Q2 2026

0:00

9:07

Speed:

Q2 2026 Earnings

9:32 • 15/7/2026

Johnson & Johnson (JNJ) - Q2 2026

0:00

9:32

Speed:

Q2 2026 Earnings

7:07 • 15.7.2026

Johnson & Johnson (JNJ) - Q2 2026

0:00

7:07

Speed:

All Episodes

EN - English (2) CN - 中文 (2) FR - Français (2) ES - Español (2) DE - Deutsch (2)

Q2 2026 Earnings

6:21

Johnson & Johnson's Q2 2026 sales grew 5.6% to $25.3B, beating guidance and raising full-year outlook to $100.6B, driven by strong Innovative Medicine and new product momentum.